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Evaluation of critical congenital heart defects screening using
pulse oximetry in the neonatal intensive care unit
K Van Naarden Braun1,2, R Grazel2,3, R Koppel4, S Lakshminrusimha5, J Lohr6, P Kumar7, B Govindaswami8, M Giuliano9, M Cohen10,
N Spillane9, P Jegatheesan8, D McClure11, D Hassinger12, O Fofah13, S Chandra14, D Allen14, R Axelrod15, J Blau16, S Hudome17,
E Assing18 and LF Garg2
OBJECTIVE: To evaluate the implementation of early screening for critical congenital heart defects (CCHDs) in the neonatal
intensive care unit (NICU) and potential exclusion of sub-populations from universal screening.
STUDY DESIGN: Prospective evaluation of CCHD screening at multiple time intervals was conducted in 21 NICUs across five states
(n= 4556 infants).
RESULTS: Of the 4120 infants with complete screens, 92% did not have prenatal CHD diagnosis or echocardiography before
screening, 72% were not receiving oxygen at 24 to 48 h and 56% were born ⩾ 2500 g. Thirty-seven infants failed screening (0.9%);
none with an unsuspected CCHD. False positive rates were low for infants not receiving oxygen (0.5%) and those screened after
weaning (0.6%), yet higher among infants born at o28 weeks (3.8%). Unnecessary echocardiograms were minimal (0.2%).
CONCLUSION: Given the majority of NICU infants were ⩾ 2500 g, not on oxygen and not preidentified for CCHD, systematic
screening at 24 to 48 h may be of benefit for early detection of CCHD with minimal burden.
Journal of Perinatology (2017) 37, 1117–1123; doi:10.1038/jp.2017.105; published online 27 July 2017
INTRODUCTION
Delayed detection of critical congenital heart defects (CCHD) may
result in significant morbidity or mortality, and thus early
recognition is crucial.1,2 Screening using pulse oximetry has
become a near-universal tool to aid in early identification of
CCHD.3,4 Many states require screening of all infants irrespective of
clinical status or setting, posing unique considerations for
implementation in the neonatal intensive care unit (NICU).4
Established CCHD screening algorithms include specified
saturation thresholds with recommended timing between 24 to
48 h of age; parameters intended for application to well infants.5,6
Feasibility of screening for the NICU population has been
questioned given complexities such as oxygen requirements and
extreme prematurity. Approximately 8% of all newborns receive
care in a NICU where frequent physical examination, extended
hospitalization and continuous pulse oximetry monitoring are
common.7,8 In this setting, abnormal findings may lead to a
diagnosis of CCHD before screening. Lack of specifications for
NICU screening and concerns of higher false positive rates (FPRs)
have led some units to exclude NICU infants from CCHD screening
with the assumption that routine monitoring is sufficient to
detect unsuspected CCHD.9 Yet, generalizing a lower risk of
undetected CCHD to all NICU infants may be problematic given
different levels of NICU care and the sizable population of infants
born at ⩾ 2500 g or ⩾ 37 weeks who approximate the well-baby
population.7,9
Existing literature on CCHD screening in the NICU in US
populations is limited.10–13 Faced with mandated screening and
minimal empiric evidence to guide implementation in the NICU,
salient questions have been raised regarding appropriate exclu-
sion criteria, timing, influence of supplemental oxygen and
resource utilization. We performed a prospective, multicenter
evaluation of CCHD screening in the NICU. Our objectives were to
evaluate the feasibility and burden associated with (1) early timing
options for screening and (2) exclusion of infants with a prenatal
CHD diagnosis, echocardiography conducted before screening or
those born at o28 weeks from universal CCHD screening in
the NICU.
METHODS
Screening protocol
The screening protocol consisted of two stages (Figure 1). Stage 1 was
targeted for all infants at 24 to 48 h after admission. Stage 2 was
conducted on infants who were receiving supplemental oxygen (any mode
of delivery) at 24 to 48 h and was optimally performed within 24 to 48 h
after weaning. Two widely referenced CCHD screening algorithms were
used in the evaluation. These included the New Jersey (NJ)-recommended
algorithm (fail or rescreen criteria: o95% in one extremity (right hand or
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either foot) and/or 43% differential in saturations)5 and the American
Academy of Pediatrics (AAP)-endorsed algorithm (fail or rescreen criteria:
o95% in both extremities (right hand and either foot) and/or 43%
differential in saturations).6 Participating NICUs used either the NJ
recommended (n= 18) or AAP (n=3) algorithm for the evaluation. For
this evaluation, both the NJ- and AAP-endorsed algorithms were modified
at stage 1 for infants receiving oxygen. This modification removed the
rescreening requirement for saturations o95% if results were consistent
with clinical management (for example, lower target saturations for
premature infants). The modification was intended to avoid unnecessary
repeat screening attempts while aiding in early detection of aortic arch
anomalies. Therefore, for infants on oxygen at Stage 1, rescreening was
only required for43% differential between pre- and post-ductal readings.
Screening results of o95% that did not necessitate rescreening were
considered conditional passes. Conversely, saturations of o95% without a
corresponding clinical explanation were regarded as fails. NJ- or AAP-
endorsed algorithms were used without modification at Stage 2. Infants
with a complete screen performed upon discharge with no Stage 1 or
Stage 2 results were categorized as having a predischarge screen. For
analysis of screening results, we universally applied the NJ thresholds
because all failed screens per the AAP algorithm would also fail the NJ
algorithm. As the majority of sites implemented the NJ algorithm and
these thresholds are inclusive of the fail and rescreen criteria as defined by
the AAP, the NJ thresholds were analytically applied to all screening results.
Deidentified infant data were collected via a secure, web-based instrument
and included information on birth weight, gestational age, prenatal CHD
diagnosis, echocardiogram before the screen, age at time of screen(s),
pulse oximetry screening values, receipt of supplemental oxygen at 24 to
48 h and/or at time of discharge, if on oxygen and results of o95%
whether this was consistent with their clinical profile and final diagnosis.
Study population
This evaluation included infants admitted to 21 level III and IV NICUs14 in
five states: California (1), Illinois (1), New Jersey (9), New York (5) and
Minnesota (5). Participation was voluntary with no funding provided.
Infants born between 1 February 2015 and 30 September 2015 with a NICU
stay of 423 h and at least one set of screening results were eligible for
inclusion. Infants with a prenatal CHD diagnosis and/or echocardiography
before screening (preidentifying factors) were included to evaluate
universal screening in the NICU. Transfers to the NICU after failed
screening on mother–baby units or well-baby nurseries were excluded.
Of the 4556 enrolled infants, a total of 436 infants were excluded. Forty-
seven infants (1%) were excluded for not having a complete set of
screening results; initial pre-and post-ductal results required a rescreen
that was not performed (Figure 2). Infants with a Stage 1 screen performed
⩾ 56.5 h after NICU admission (referenced as late Stage 1) were also
excluded (n=389 infants, 8.5%; Figure 2). In practice, the strict cutoff of
48 h did not allow for minor variation because of practical implementation
factors (for example, time of day) that may have resulted in a calculated
screening time of slightly 448 h. To accommodate reasonable, real-world
application with the goal of early screening, we used the s.d. (7.5 h) of the
24 to 48 h stage 1 target timing window to analytically define Stage 1
screens as 423 to o56.6 h (n=160). Infants with incomplete and late
Stage 1 screens were more likely to have been on oxygen and born at
o28 weeks than infants with complete screening results.
The final sample consisted of 4120 infants with at least one set of
complete screening results within a defined stage(s): 83.1% were screened
at stage 1 (n= 3423), 20.2% at stage 2 (n= 833) and 5.6% predischarge only
(n=232) (Figure 2). Quality assurance was conducted by each site on 29%
of the final sample. This evaluation was deemed public health practice by
each site’s institutional review board.
Statistical analyses
FPRs for CCHD were calculated as the number of infants without CCHD
who failed on the first set of screening results divided by the number of
infants without CCHD who were screened multiplied by 100 using the
NJ-recommended algorithm5 with modification for infants on oxygen. In
STAGE 1: Screen ALL infants 24-48 hours of age including those on supplemental oxygen
Perform and document pulse oximetry in both RIGHT HAND and either FOOT using
State/Hospital Specific Protocol   
If on supplemental oxygen, implement state/hospital specific
protocol with following modifications 
First set of screening measurements
is a difference of 4% or greater-
RESCREEN 1 hour apart up to 2 times
First set of screening measurements
is < 95% and consistent with clinical
profile AND difference is 3 or less-    
DO NOT RESCREEN 
STAGE 2: Screen 24-48 hours after weaning to room air. 
Pre-discharge screen
Performed per hospital protocol or if Stage 1 or Stage 2 screening was not done.
If difference 3%
or less- PASS  If difference 4%or greater after 3
attempts- FAIL  
Figure 1. Multistage algorithm for evaluation of critical congenital heart defects screening in the neonatal intensive care unita.
aImplementation of this screening algorithm should not take the place of clinical judgment and intervention.
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Table 1. Characteristics of infants in evaluation of critical congenital heart defects (CCHD) screening in the neonatal intensive care unit, February to
September 2015 (N = 4556)
Total,
N= 4556
Complete screensa,
N= 4120
Stage 1b, N= 3423
On O2,
n= 579
Not on O2,
n=2844
Stage 2c,
N=833
Length of stay (hours) % % % % %
Short stay (o144) 43.9 43.8 13.3 56.1 18.6
Long stay (⩾144) 56.1 56.2 86.7 43.9 81.4
Prenatal CHD diagnosis and/or echo before screen 9.0 8.5 15.9 5.5 13.7
Prenatal CHD diagnosis only 0.5 0.5 0.2 0.6 0.1
Echo before screen only 7.2 6.7 13.5 3.7 12.7
Prenatal CHD diagnosis and echo before
screen
1.3 1.3 2.2 1.2 0.8
Neither prenatal CHD diagnosis nor echo before
screen
91.0 91.5 84.1 94.5 86.3
Gestational age (weeks)
o28 4.3 4.2 14.7 0.7 9.7
28–31 8.9 9.0 20.9 4.3 21.5
32–36 38.2 38.8 35.4 39.5 39.1
⩾ 37 48.6 48.1 29.0 55.4 29.7
Median 36 36 34 37 34.0
Range 23–42 23–42 23–41 23–42 23–42
Birth weight (grams)
o1000 4.3 4.1 13.6 0.9 9.5
1000–1499 7.1 7.2 17.6 3.7 16.1
1500–2499 32.0 32.4 30.7 31.9 33.6
⩾ 2500 56.7 56.3 38.0 63.4 40.8
Median 2700 2690 2090 2891 2180
Range 325–6100 325–6100 325–6100 510–5639 410–6100
aComplete screens within specific stage time definitions. bStage 1: screening targeted for 24–48 h after admission. cStage 2: screening targeted for 24–48 h
after weaning from supplemental oxygen.
Total Stage 1
N= 3423   
On oxygen
Modified protocol
N= 579 
No oxygen
Normal nursery protocol
N= 2844
Total Number of Infants in NICU Evaluation
N= 4556
Pre-discharge Only4
N= 232
Exclusions N= 436
Incomplete Screens1 N= 47
Late Stage 1 Only2 N= 389  
Total Number of Infants with at Least One Set of Complete Screening Results within Defined Stage(s)
N= 4120 
Total Stage 2
N= 8333 
Figure 2. Flowchart of participants in critical congenital heart defects screening neonatal intensive care unit (NICU) evaluation, February 2015
to September 2015. 1Infants for whom one pre-and post-ductal result was obtained, the results required a re-screen to be performed, and this
re-screen was not done. 2Infants with only a Stage 1 screen which was performed after defined Stage 1 time window (greater than 56.7 hours).
3Includes infants on oxygen at 24 to 48 h after birth screened at Stage 1 and Stage 2 (n=368), and infants on oxygen at 24 to 48 h after birth
with only a Stage 2 screen (n=465) because: a) NICU did not screen infants on oxygen or b) Stage 1 screen was missed or incomplete. 4Infants
only screened within 4 days of discharge (N=112 not on oxygen at Stage 1).
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addition, FPRs were calculated for CCHD and CHD combined. The χ2 tests
of significance at Po0.05 were used.
Implementation survey
An 11-question survey was administered to qualitatively assess implementa-
tion of the multistage screening protocol. This survey was completed by 258
nurses with representation from each NICU. A 10-point Likert scale was used
to assess burden of implementation with 1=no burden and 10=extremely
burdensome.15 The mean score was interpreted as: low burden= 1 to 3.9,
moderate burden=4.0 to 6.9, and high burden=7 to 10.15
RESULTS
Of the 4120 infants with complete, appropriately timed screens,
43.8% were discharged from the NICU before 5 days (o144 h),
71.7% were not receiving supplemental oxygen at 24 to 48 h,
56.3% were born ⩾ 2500 g and 48.1% were born at ⩾ 37 weeks
(Table 1). In addition, 91.5% of infants did not have a prenatal CHD
diagnosis or echocardiogram before the screen. The majority of
our NICU population (67.7%, n= 2791) had no preidentifying
factor and were not on oxygen, comprising the subgroup of
infants who may benefit from early screening at 24 to 48 h.
Multistage screening results
Of the 3423 infants screened at Stage 1, 0.9% failed (n= 32) and
99.1% passed (n= 3391), inclusive of 138 conditional passes. Of
Stage 2 screens, 0.6% failed (n= 5) and 99.4% passed (n= 828). Of
infants with only a predischarge screen (n= 232), 100% passed.
Use of supplemental oxygen
Of the 579 infants screened on oxygen at Stage 1, 97.9% passed
and 2.1% failed using the modified algorithm. Without modifica-
tion, the fail rate would increase to 25.9% that is, if conditional
passes are considered fails) (Table 2). Despite the modification,
screening results were significantly less favorable for infants on
oxygen than for their counterparts on room air (Po0.002).
Exclusion criteria
Prenatal CHD diagnosis and/or echocardiogram before the screen.
Of the 32 infants who failed Stage 1, the majority (66%, n= 21) did
not have a potential exclusion criteria of a prenatal CHD diagnosis
and/or echocardiogram before the screen. One of these infants
with previously unsuspected CHD was identified by screening
(Supplementary Material I). Infants without a preidentifying factor
on room air had significantly lower fail rates (0.5%) than those on
oxygen (1.6%, Po0.004). Among infants who failed the Stage 1
screen without a preidentifying factor, 38% (n= 8) were on
oxygen, 5 of whom had an echocardiogram in response to their
screen that yielded a patent foramen ovale or patent ductus
arteriosis. As anticipated, overall, infants with a prenatal CHD
diagnosis and/or echocardiogram before the screen had higher
fail rates at Stage 1 than those without a preidentifying factor
(Po0.0001) (Table 2). For these preidentified infants, receipt of
supplemental oxygen had no significant influence on Stage 1 pass
and fail rates.
Gestational age and birth weight. Stage 1 fail rates were
significantly higher among infants born at o28 weeks and
o1000 g compared with those born at higher birth weights and
older gestational ages (Po0.0003 and Po0.0001, respectively)
(Table 2). The proportion of conditional passes increased with
decreasing gestational age; most notably for infants born at
o28 weeks for whom 41.2% of passes were conditional and
would have qualified as rescreens or fails using a nonmodified
protocol. Infants born at ⩾ 37weeks or ⩾ 2500 g and receiving
oxygen had higher fail rates (4.2% and 3.6%, respectively) than
comparable infants not on oxygen (1.0% and 1.0%, respectively).
Discharge diagnoses
Of the 4556 total infants, 24 had CCHD yielding a prevalence of 5.3
per 1000 (95% confidence interval (CI): 3.5, 7.9) in our NICU
population. In all, 17 infants with CCHD had complete screening
results, 9 passed the screen (52.9%), 3 were conditional passes
(17.6%) and 5 failed (29.4%) (Supplementary Material II). No infants
Table 2. Final Stage 1 screening outcomes by potential exclusion criteria, evaluation of critical congenital heart defects (CCHD) screening in the
neonatal intensive care unit, February to September 2015 (N= 3423)
On oxygen
N= 579
Not on oxygen
N=2844
Total pass Pass Conditional passa Failb Pass Failb
N % % % % N % %
Total infants screened at Stage 1 579 97.9 74.1 23.8 2.1 2844 99.3 0.7
Prenatal CHD diagnosis and/or echo before screen 92 95.7 68.5 27.2 4.3 157 95.5 4.5
Neither prenatal diagnosis nor echo before screen 487 98.4 75.2 23.2 1.6 2687 99.5 0.5
Gestational age (weeks)
o28 85 97.6 56.5 41.2 2.4 21 90.5 9.5
28–31 121 99.2 74.4 24.8 0.8 123 100.0 –
32–36 205 99.0 74.6 24.4 1.0 1124 99.8 0.2
⩾ 37 168 95.8 82.1 13.7 4.2 1576 98.4 1.0
Birth weight (g)
o1000 79 97.5 64.6 32.9 2.5 27 92.6 7.4
1000–1499 102 100.0 67.6 32.4 -- 106 100.0 –
1500–2499 178 98.9 75.3 23.6 1.1 907 100.0 –
⩾ 2500 220 96.4 79.5 16.8 3.6 1804 99.0 1.0
aInfants on supplemental oxygen were deemed conditional passes if saturations o95%, yet differential o4% and saturations were consistent with clinical
profile. Rescreening only performed as per the modified arm of the algorithm. Percentage is of all infants on oxygen who passed the screen. bFail as per the
New Jersey-recommended algorithm.
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with CCHD were identified because of the screen. Of the 12 false
negative screens (including the 3 conditional passes), 5 infants had
coarctation of the aorta. Although 2 of 12 infants did not have a
preidentifying factor, all were symptomatic before screening (for
example, murmur, tachypnea, desaturations). Of the 47 infants who
were excluded because of incomplete screening results, 6 had
CCHD and were symptomatic before the screen. In the absence of
complete screening results, we cannot conclusively categorize
these infants as either true positive or false negative screens.
The remaining infants with complete screens had noncardiac
final diagnoses (86.6%), an unresolved patent foramen ovale or
patent ductus arteriosis (10.1%), noncritical CHDs (2.8%) or expired
after screening (0.2%). Only 0.3% of infants with noncardiac
diagnoses failed at Stage 1 or Stage 2. Approximately 3.9% of
infants with an unresolved patent foramen ovale and/or patent
ductus arteriosis confirmed by echocardiogram failed either the
Stage 1 or Stage 2 screen. The proportion of infants with CHD with
a failed screen was 3.5%. One infant with a ventricular septal
defect (VSD) was identified due to screening (Supplementary
Material I).
Assessment of burden
Applying the NJ-recommended algorithm with modification, the
overall FPR of NICU screening was 0.8% (95% CI: 0.6, 1.1; Table 3).
The overall FPR increased to 4.0% (95% CI: 3.5, 4.7) when
conditional passes were treated as fails. FPRs were highest among
infants screened on oxygen (2.1%, 95% CI: 1.2, 3.7) and those born
at o28 weeks (3.8%, 95% CI: 1.4, 10.2). Compared with Stage 1
screening on oxygen (2.1%), FPRs were significantly lower for
Stage 1 not on oxygen (0.5%) and Stage 2 (0.6%) (Po0.0001 and
Po0.01, respectively). Given our finding of one infant with an
unsuspected VSD identified by screening, FPRs were examined for
the broader group of CHD and were remarkably comparable to
FPRs for detection of CCHD (Table 3).
When restricted to infants without a prenatal CHD diagnosis or
echocardiogram before the screen, the FPR using the modified
algorithm decreased to 0.6% overall (95% CI: 0.4, 0.9); 1.6% and
0.6% for Stage 1 on and off oxygen respectively, and 0.3% for
Stage 2. FPRs for this restricted group were not significantly
different from those using the entire sample (P= 0.367).
Overall, 13.1% of infants had an echocardiogram during
hospitalization (n= 540/4120), yet only 7 (0.2%) were performed
in response to failed screens at any stage, one of which identified
the CHD. Based on quantitative survey findings, nursing staff
reported screening was of low burden during this evaluation
(mean= 3.5). Approximately 80% of survey respondents reported
that having a NICU-specific CCHD screening protocol facilitated
differentiation between screening and routine monitoring with
pulse oximetry. In addition, 81% responded that utilization of the
evaluation protocol increased awareness of unsuspected CHD in
the NICU.
DISCUSSION
Our findings demonstrate that the NICU population is hetero-
geneous; with a large percentage of infants born ⩾ 2500 g, not
receiving supplemental oxygen and discharged within 5 days after
birth, therefore similar to the well-baby population for which
CCHD screening was initially intended.8 In the absence of
systematic screening, approximately two-thirds of our NICU
population (that is, those without a preidentifying factor and not
receiving supplemental oxygen) were at risk for late detection of
unsuspected CCHD and had the potential to benefit from early
systematic screening at 24 to 48 h. This estimate of infants who
may benefit from screening at 24 to 48 h is likely higher in
communities with lower prenatal detection rates as the NICUs in
our evaluation represented high resource settings that are likely to
have a lower rate of undiagnosed CCHD. For all newborns,
regardless of setting, clinical exam and pulse oximetry screening
are used in tandem to evaluate the presence of CCHD. Despite
more intensive clinical monitoring, admission to a NICU does not
preclude the potential for unrecognized CCHD and/or CHD as
evidenced by our finding that screening identified one infant with
an unsuspected noncritical CHD. As data demonstrate that critical
and noncritical CHD are associated with neurodevelopmental
delays, early identification and intervention across all CHD is
important.16 Consistent with our findings, a recent international,
single-center study evaluated pulse oximetry screening upon
admission in conjunction with clinical exam and supported the
feasibility of screening in the NICU.17 Although this study screened
infants with pulse oximetry at o24 h, their recommendation for
universal screening was made despite a markedly higher overall
FPR (55.8%) than found in our evaluation.
Concerns regarding timing and appropriateness of screening
among NICU infants receiving supplemental oxygen have been
noted.10–13,18,19 Our protocol of screening infants at 24 to 48 h,
including those receiving supplemental oxygen, aimed to address
these issues. Aware that target saturations for infants receiving
supplemental oxygen may be intentionally lower, our modification
of only requiring a rescreen for 43% pre- and post-ductal
differential or saturations o95% inconsistent with clinical profile,
afforded the ability to minimize false positives and potentially aid
in early detection of aortic arch anomalies. Our modification did
significantly reduce the overall FPR (0.8%) compared with when
no modification was implemented (4.1%). Of important note, the
FPR was further reduced when infants on oxygen at 24 to 48 h
were screened as soon as possible after weaning (0.6%) and
strikingly comparable to those not on oxygen at 24 to 48 h (0.5%).
Difficulties were observed in tracking the timing of multiple
screens for infants receiving oxygen at 24 to 48 h highlighting
challenges with implementing the modified multistage protocol.
Additional complexities arose, including misinterpretation of the
Table 3. False positive rates (FPRs)a applying New Jersey-
recommended critical congenital heart defects (CCHD) screening
algorithmb
Overall FPR FPR among infants without a
prenatal CHD diagnosis or
echocardiogram before screen
% (95% CI) % (95% CI)
FPR for CCHD
Overall 0.8 (0.6, 1.1) 0.6 (0.4, 0.9)
Stage 1
On oxygen 2.1 (1.2, 3.7) 1.6 (0.8, 3.3)
No oxygen 0.5 (0.3, 0.9) 0.6 (0.4, 0.9)
Extremely
premature
(o28 weeks)
3.8 (1.4, 10.2) 4.0 (1.5, 10.8)
Stage 2 0.6 (0.3, 1.4) 0.3 (0.1, 1.1)
FPR for CCHD+noncritical CHD
Overall 0.7 (0.5, 1.0) 0.6 (0.4, 0.9)
Stage 1
On oxygen 2.1 (1.1, 3.7) 1.7 (0.9, 3.5)
No oxygen 0.5 (0.3, 0.9) 0.6 (0.4, 0.9)
Extremely
premature
(o28 weeks)
4.0 (1.5, 10.6) 4.2 (1.6, 11.2)
Stage 2 0.4 (0.1, 1.2) 0.3 (0.1, 1.2)
Abbreviations: CHD, congenital heart defects; CI, confidence interval.
aFail/rescreen=o95% either or43%. bConditional passes are considered
passes in all FPR calculations.
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43% differential criteria, although this challenge is not unique to
the NICU.20
Application of exclusion criteria based on preidentifying factors
and gestational age is not straightforward. The use of echocardio-
graphy alone for exclusion of infants from screening raised
concerns regarding variability in echocardiogram timing and
quality, and accessibility of pediatric specialty expertise for
interpretation to rule out CCHD. A prenatal CHD diagnosis alone
affected a very small proportion of the NICU population, resulting
in negligible added burden. Furthermore, collection of pulse
oximetry screening values for infants with confirmed CHD can
provide useful insight into the predictive potential of alternative
saturation thresholds for improving the sensitivity of CCHD
screening. Although infants born at o28 weeks or o1000 g
also comprised a small proportion of our NICU population, the
higher incomplete screen rates and FPRs at 24 to 48 h for this
subgroup compared with other gestational ages and birth weights
emphasize the challenges for the timing of CCHD screening in this
population. As the goal of universal screening is early detection,
screening infants born at o28 weeks or o1000 g as soon as
possible when medically stable is a reasonable goal.
Our qualitative survey findings provided additional endorse-
ment for systematic NICU screening. Consistent with evidence of
the effectiveness of cognitive forcing strategies to decrease
diagnostic error, nursing staff reported that implementation of a
systematic, NICU protocol on all infants instilled a heightened
awareness among clinicians of the potential for underlying,
unsuspected CCHD.21 Furthermore, clinicians reported that
application of exclusion criteria within the NICU introduces
practice variation that may increase the likelihood of missed
screens for the remainder of the population.
We quantified the burden of our multistage protocol in several
ways. First, the number of echocardiograms conducted in direct
response to failed screens was extremely low and one resulted in
early identification of a VSD. As the number of fails and
unnecessary echocardiograms related to Stage 2 were also
minimal, screening as soon as possible after weaning from
oxygen is reasonable. This is particularly applicable for longer
stay infants for whom screening closer to the time of discharge
might be too late for early identification of CCHD. In addition, the
majority of echocardiograms performed in response to failed
screens were among infants on oxygen at 24 to 48 h with an
unresolved patent foramen ovale or patent ductus arteriosis,
providing further evidence for screening infants as soon as
possible after weaning. Second, we quantified FPRs as a
mechanism to evaluate burden of screening. Of the four US
studies conducted, three reported no failed screens10–12 with the
fourth reporting13 a FPR (0.7%) that was similar to our overall
findings, yet higher than that of asymptomatic newborns.22
de-Wahl Granelli et al.23 reported a FPR of 0.2% in the well-baby
nursery for infants screened using both extremities at 424 h
excluding those with a prenatal CHD diagnosis. Although
caution is needed in making direct comparisons between FPRs
from our evaluation with those of well-baby populations, our
overall FPR (0.8%) was more comparable when restricted to
infants who were not on oxygen at 24 to 48 h (0.5%) and among
infants after weaning from oxygen without a preidentifying factor
(0.3%). Our FPR among infants born at o28 weeks was
significantly higher than all other gestational age groups,
emphasizing the complexities of screening this sub-population.
As FPRs for CCHD categorize infants with a noncritical CHD
identified by screening as a false positive, we also calculated
FPRs for all CHD, critical and noncritical combined.24 These rates
were quite comparable to those restricted to CCHD, further
supporting the minimal added burden of screening all NICU
infants with the potential benefit of identifying other unsus-
pected, noncritical conditions. Finally, the minimal burden
reported by nursing staff during the evaluation demonstrated
that CCHD screening is feasible in the NICU population. These
findings coupled with the added benefits of increased awareness
of unsuspected CHD and clarification of screening versus
monitoring suggest that CCHD screening may have a meaningful
role in the NICU without the significant added burden as
previously perceived.
This evaluation was strengthened by its ability to prospectively
implement a multi-stage protocol. As participating NICUs repre-
sented closely monitored infants of varying levels of acuity, we
were able to assess the population for which CCHD screening was
questionable. Our ability to collect individual-level information on
preidentifying factors enabled us to further refine the population
potentially benefiting from screening. Information on echocardio-
grams performed in response to failed screens was crucial for
quantifying resource burden. Although the overall sensitivity of
pulse oximetry screening in our NICU evaluation was low, it is
essential to incorporate preidentification of CCHD when evaluat-
ing the unique contribution of pulse oximetry for early detection.
As the majority of our infants with CCHD were identified before
screening, we did not have sufficient power to conclude that
screening with pulse oximetry in the NICU is not of benefit.
Conversely, two of the nine infants with false negative screens
were not preidentified, suggesting necessary caution against
overreliance on either clinical assessment or screening alone for
the detection of CCHD in the NICU. Further investigation is needed
on the implications of applying different screening thresholds to
specific NICU sub-populations as well as feasible options for early
identification of aortic arch anomalies.
Given the majority of our population comprised infants
⩾ 2500 g, not on oxygen and without either preidentifying
factor, CCHD screening targeted at 24 to 48 h may benefit NICU
infants who approximate the well-baby population and are at
potentially higher risk for undetected CCHD. Although challenges
arose when early screening was conducted on the small
population of infants born at o28 weeks and those receiving
supplemental oxygen, exclusion of sub-populations within the
NICU introduces practice variation that may potentially result in
missed screens. Collectively, the evidence from our evaluation
supports the feasibility, minimal burden and potential benefits of
implementing systematic early screening in the NICU for
undetected CCHD.
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